124 related articles for article (PubMed ID: 36870373)
41. Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin.
Campbell MJ; Elstner E; Holden S; Uskokovic M; Koeffler HP
J Mol Endocrinol; 1997 Aug; 19(1):15-27. PubMed ID: 9278857
[TBL] [Abstract][Full Text] [Related]
42. Limited in vitro efficacy of CYP17A1 inhibition on human castration resistant prostate cancer.
Kosaka T; Miyajima A; Yasumizu Y; Miyazaki Y; Kikuchi E; Oya M
Steroids; 2014 Dec; 92():39-44. PubMed ID: 25150014
[TBL] [Abstract][Full Text] [Related]
43. New platinum(II) complexes conjugated at position 7α of 17β-acetyl-testosterone as new combi-molecules against prostate cancer: design, synthesis, structure-activity relationships and biological evaluation.
Fortin S; Brasseur K; Morin N; Asselin É; Bérubé G
Eur J Med Chem; 2013 Oct; 68():433-43. PubMed ID: 23994871
[TBL] [Abstract][Full Text] [Related]
44. Novel 2,4,5-trisubstituted oxazole derivatives: synthesis and antiproliferative activity.
Liu XH; Lv PC; Xue JY; Song BA; Zhu HL
Eur J Med Chem; 2009 Oct; 44(10):3930-5. PubMed ID: 19423198
[TBL] [Abstract][Full Text] [Related]
45. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of methoxycarbonylpyrazolylandrostene derivatives, and their potential inhibitory effect on androgen biosynthesis and cell proliferation.
Szabó N; Iványi Z; Szécsi M; Julesz J; Mernyák E; Huber J; Wölfling J; Minorics R; Zupkó I; Schneider G
Steroids; 2015 Jun; 98():143-52. PubMed ID: 25804762
[TBL] [Abstract][Full Text] [Related]
47. Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17 alpha-hydroxylase-C17,20-lyase (P450(17) alpha): potential agents for the treatment of prostate cancer.
Njar VC; Kato K; Nnane IP; Grigoryev DN; Long BJ; Brodie AM
J Med Chem; 1998 Mar; 41(6):902-12. PubMed ID: 9526564
[TBL] [Abstract][Full Text] [Related]
48. Design and synthesis of D-ring steroidal isoxazolines and oxazolines as potential antiproliferative agents against LNCaP, PC-3 and DU-145 cells.
Banday AH; Giri AK; Parveen R; Bashir N
Steroids; 2014 Sep; 87():93-8. PubMed ID: 24910245
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and cytotoxic activities of some 2-arylnaphtho[2,3-d]oxazole-4,9-dione derivatives on androgen-dependent (LNCaP) and androgen-independent (PC3) human prostate cancer cell lines.
Brandy Y; Ononiwu I; Adedeji D; Williams V; Mouamba C; Kanaan Y; Copeland RL; Wright DA; Butcher RJ; Denmeade SR; Bakare O
Invest New Drugs; 2012 Aug; 30(4):1709-14. PubMed ID: 21243402
[TBL] [Abstract][Full Text] [Related]
50. Design, synthesis and apoptosis inducing effect of novel (Z)-3-(3'-methoxy-4'-(2-amino-2-oxoethoxy)-benzylidene)indolin-2-ones as potential antitumour agents.
Senwar KR; Reddy TS; Thummuri D; Sharma P; Naidu VG; Srinivasulu G; Shankaraiah N
Eur J Med Chem; 2016 Aug; 118():34-46. PubMed ID: 27128173
[TBL] [Abstract][Full Text] [Related]
51. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
52. Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
Day JM; Tutill HJ; Foster PA; Bailey HV; Heaton WB; Sharland CM; Vicker N; Potter BV; Purohit A; Reed MJ
Mol Cell Endocrinol; 2009 Mar; 301(1-2):251-8. PubMed ID: 18786604
[TBL] [Abstract][Full Text] [Related]
53. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
Sanderson JT; Clabault H; Patton C; Lassalle-Claux G; Jean-François J; Paré AF; Hébert MJ; Surette ME; Touaibia M
Bioorg Med Chem; 2013 Nov; 21(22):7182-93. PubMed ID: 24080105
[TBL] [Abstract][Full Text] [Related]
54. New Approaches for the Synthesis of Fused Thiophene, Pyrazole, Pyran and Pyridine Derivatives with Anti-Proliferative Together with c-Met Kinase and Prostate Cancer Cell Inhibitions.
Mohareb RM; Milad YR; El-Ansary RA
Anticancer Agents Med Chem; 2021; 21(13):1751-1766. PubMed ID: 33176664
[TBL] [Abstract][Full Text] [Related]
55. Specificity of anti-prostate cancer CYP17A1 inhibitors on androgen biosynthesis.
Udhane SS; Dick B; Hu Q; Hartmann RW; Pandey AV
Biochem Biophys Res Commun; 2016 Sep; 477(4):1005-1010. PubMed ID: 27395338
[TBL] [Abstract][Full Text] [Related]
56. The role of CYP17A1 in prostate cancer development: structure, function, mechanism of action, genetic variations and its inhibition.
Kmeťová Sivoňová M; Jurečeková J; Tatarková Z; Kaplán P; Lichardusová L; Hatok J
Gen Physiol Biophys; 2017 Dec; 36(5):487-499. PubMed ID: 29372682
[TBL] [Abstract][Full Text] [Related]
57. Anticancer activity of a novel selective CYP17A1 inhibitor in preclinical models of castrate-resistant prostate cancer.
Toren PJ; Kim S; Pham S; Mangalji A; Adomat H; Guns ES; Zoubeidi A; Moore W; Gleave ME
Mol Cancer Ther; 2015 Jan; 14(1):59-69. PubMed ID: 25351916
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and activity of novel 16-dehydropregnenolone acetate derivatives as inhibitors of type 1 5α-reductase and on cancer cell line SK-LU-1.
Silva-Ortiz AV; Bratoeff E; Ramírez-Apan T; Heuze Y; Sánchez A; Soriano J; Cabeza M
Bioorg Med Chem; 2015 Dec; 23(24):7535-42. PubMed ID: 26631442
[TBL] [Abstract][Full Text] [Related]
59. Synthesis of 5H-indeno[1,2-b]pyridine derivatives: Antiproliferative and antimetastatic activities against two human prostate cancer cell lines.
Charris KE; Rodrigues JR; Ramírez H; Fernandez-Moreira E; Ángel JE; Charris JE
Arch Pharm (Weinheim); 2021 Aug; 354(8):e2100092. PubMed ID: 33928662
[TBL] [Abstract][Full Text] [Related]
60. Effect of dehydroepiandrosterone derivatives on the activity of 5α-reductase isoenzymes and on cancer cell line PC-3.
Bratoeff E; Garrido M; Ramírez-Apan T; Heuze Y; Sánchez A; Soriano J; Cabeza M
Bioorg Med Chem; 2014 Nov; 22(21):6233-41. PubMed ID: 25261928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]